comparemela.com

Latest Breaking News On - Kuros biosciences - Page 12 : comparemela.com

Kuros Biosciences doing extremely well in innovative spinal fusion treatments

Kuros Biosciences (SWX:KURN, OTC:CSBTF) CEO Joost de Bruijn speaks to Thomas Warner from Proactive about the innovative work the spinal fusion.

Kuros Biosciences Reports Results for First Half 2023

Kuros Biosciences AG / Key word: Half Year Results Kuros Biosciences Reports Results for First Half 2023 09-Aug-2023 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.